New drugs for Alzheimer's have been hailed as a breakthrough – but their shortcomings are profound
Unlike their many predecessors, these drugs were the first to slow cognitive decline.
Source: scroll.in
Aduhelm Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Aduhelm Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Aduhelm Approval Today - Breaking & Trending Today
With new Alzheimer's drug, Biden FDA is not following the science
The prominent economist Milton Friedman said that in order to understand the motivation of a person or organization, you must look for the self-interest. So where do regulators' interests lie? Not always in the public interest, alas, but in increased responsibilities, budgets, bureaucratic empires, and avoiding bad decisions.
Source: washingtonexaminer.com
Alzheimer's Association says accelerated drug approvals, like for Aduhelm, necessary in search for treatment | WFAE 90.7
Medicare's decision to limit coverage for a controversial new Alzheimer's drug has prompted an outcry among Alzheimer's advocates. The drug is Aduhelm, and despite widespread enthusiasm for it among Alzheimer's patients and advocates, it hasn't been proven to slow the disease. The drug was given accelerated approval by the Food and Drug Administration because it reduces the plaque that develops in the brains of most Alzheimer’s patients.
Source: wfae.org